Recently, Ye et al. prepared cationic liposome nanoparticles modified with ferric oxide and studied their delivery ability to oxaliplatin (OXA) and MDC1-AS in cervical cancer cells [134]. This evidence concerns the gene MDC1 and cervical cancer.